home / stock / absi / absi quote
Last: | $3.18 |
---|---|
Change Percent: | -14.14% |
Open: | $3.39 |
Close: | $3.18 |
High: | $3.5499 |
Low: | $3.13 |
Volume: | 1,327,128 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.18 | $3.39 | $3.18 | $3.5499 | $3.13 | 1,327,128 | 07-03-2024 |
$2.97 | $2.97 | $2.97 | $3.03 | $2.915 | 841,695 | 07-02-2024 |
$3.01 | $3.08 | $3.01 | $3.125 | $2.93 | 1,138,258 | 07-01-2024 |
$3.08 | $3.04 | $3.08 | $3.17 | $2.96 | 12,564,168 | 06-28-2024 |
$3.05 | $3.09 | $3.05 | $3.2 | $2.995 | 1,511,602 | 06-27-2024 |
$3.07 | $2.92 | $3.07 | $3.11 | $2.9 | 1,313,933 | 06-26-2024 |
$2.94 | $3.05 | $2.94 | $3.15 | $2.93 | 1,675,408 | 06-25-2024 |
$3.04 | $3.03 | $3.04 | $3.11 | $2.97 | 2,158,109 | 06-24-2024 |
$3.02 | $2.98 | $3.02 | $3.02 | $2.86 | 4,598,018 | 06-21-2024 |
$2.92 | $3.5 | $2.92 | $3.5 | $2.795 | 3,968,840 | 06-20-2024 |
$3.48 | $3.42 | $3.48 | $3.59 | $3.35 | 1,491,290 | 06-19-2024 |
$3.48 | $3.42 | $3.48 | $3.59 | $3.35 | 1,491,290 | 06-18-2024 |
$3.41 | $3.99 | $3.41 | $4.015 | $3.19 | 3,283,971 | 06-17-2024 |
$3.98 | $4.35 | $3.98 | $4.37 | $3.92 | 1,763,519 | 06-14-2024 |
$4.37 | $4.98 | $4.37 | $5.2 | $4.34 | 2,706,780 | 06-13-2024 |
$4.96 | $4.68 | $4.96 | $4.98 | $4.6299 | 1,464,371 | 06-12-2024 |
$4.51 | $4.5 | $4.51 | $4.521 | $4.37 | 831,494 | 06-11-2024 |
$4.52 | $4.39 | $4.52 | $4.6 | $4.3002 | 1,096,996 | 06-10-2024 |
$4.38 | $4.28 | $4.38 | $4.38 | $4.21 | 593,644 | 06-07-2024 |
$4.37 | $4.62 | $4.37 | $4.65 | $4.24 | 898,615 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, Wash. and NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced that on July 1, 2024, the company granted a non-statutory stock option to purchase an aggregate of 613,000 shares of its common stoc...
VANCOUVER, Wash. and NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Morgan Stanley 3 rd Annual Life Sciences AI Summit on June 26-27 in New York, ...
VANCOUVER, Wash. and NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Goldman Sachs 45 th Annual Global Healthcare Conference in Miami, FL. Absci...